×
Shilpa Medicare Ltd.
↑
64.86% Gain from 52W Low
17 hours ago
•
BSE India
Intimation pursuant to receipt of reclassification application from persons related to promoters
Shilpa Medicare Ltd. has gained 36.87% in the last 3 Months
16 Jul 2025
•
Business Standard
Shilpa Medicare share price gained in trade after the company announced a positive regulatory update from the US health regulator, United States Food and Drug Administration (USFDA).
Shilpa Medicare Ltd. has gained 41.23% in the last 1 Year
16 Jul 2025
•
BSE India
This is to inform you that Shilpa Medicare''s Unit VI, at Bengaluru has received EIR from USFDA
Shilpa Medicare Ltd. has gained 36.87% in the last 3 Months
10 Jul 2025
•
Business Standard
Shilpa Medicare shares rose today after the company secured GMP certification from Saudi Arabia's SFDA for its Unit VI facility in Dabaspet, Bengaluru.
Shilpa Medicare Ltd. is trading above all available SMAs
10 Jul 2025
•
BSE India
Approval of Shilpa Medicare Limited, Unit VI, Dabaspet, Bengaluru by SFDA, Saudi Arabia
Shilpa Medicare Ltd. is trading above all available SMAs
05 Jul 2025
•
BSE India
Intimation of certified true copy of NCLT order approving the scheme of amalgamation
Shilpa Medicare Ltd. has gained 36.87% in the last 3 Months
04 Jul 2025
•
BSE India
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for quarter ended June 30, 2025
Shilpa Medicare Ltd. has gained 41.23% in the last 1 Year
04 Jul 2025
•
BSE India
Shilpa Pharma Lifesciences Limited, Unit - 1, ANVISA Audit from Brazil
Promoters released all pledges in Jun 2025 qtr.
02 Jul 2025
•
BSE India
Revision of Credit Rating
Shilpa Medicare Ltd. has gained 41.23% in the last 1 Year
28 Jun 2025
•
BSE India
NCLT order on Merger of INM Technologies Private Limited, a wholly owned subsidiary with Shilpa Medicare Limited
Shilpa Medicare Ltd. has gained 41.23% in the last 1 Year
Strengths
18
Weakness
8
Opportunity
3
Threats
1
- High DVM Mid and Small Caps (subscription)
- Benjamin Graham Value Screen
- Strong Performer, Getting Expensive (DVM)
- Strong Momentum: Price above short, medium and long term moving averages
- Consistent Highest Return Stocks over Five Years
- Annual Profit Growth higher than Sector Profit Growth
- PEG lower than Industry PEG
- High Momentum Scores (Technical Scores greater than 50)
- Relative Outperformance versus Industry over 1 Week
- Effectively using its capital to generate profit - RoCE improving in last 2 years
- Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
- Efficient in managing Assets to generate Profits - ROA improving since last 2 year
- Companies with Low Debt
- Annual Net Profits improving for last 2 years
- Book Value per share Improving for last 2 years
- RSI indicating price strength
- Stocks near 52 Week High with Significant Volumes
- Stocks Outperforming their Industry Price Change in the Quarter
- PE higher than Industry PE
- High PE (PE > 40)
- Stocks with Expensive Valuations according to the Trendlyne Valuation Score
- Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
- Declining Net Cash Flow : Companies not able to generate net cash
- Increasing Trend in Non-Core Income
- High promoter stock pledges
- Top Losers
- Mutual Funds Increased Shareholding in Past Month
- FII / FPI or Institutions increasing their shareholding
- Companies with improving valuation scores after share price falls
- MFs decreased their shareholding last quarter
Market Capitalization
Above industry Median
8,947.9
PE TTM
High in industry
114.3
PEG TTM
Below industry Median
0.8
Price to Book
Above industry Median
3.8
Operating Profit Margin Qtr %
Below industry Median
23.2
Dividend yield 1yr %
0
Oper Rev Qtr
13.4% incr over last year
330.8
Net Profit Qtr
41% decr over last year
14.5
Operating Profit Qtr
9.6% incr over last year
76.8
Operating Revenue TTM
11.7% incr over last year
1,286.4
Net profit TTM
145.9% incr over last year
78.3
Basic EPS TTM
145.7% incr over last year
8.0
RSI
RSI is mid-range
58.9
MFI
MFI Overbought
75.6
PAST EVENT
•
May 26, 2025
Board Meeting - Audited Results & Final Dividend
The latest board meeting for Shilpa Medicare Ltd. took place on May 26, 2025, for the purpose of Audited Results & Final Dividend
.
*All Financial parameters are in Cr INR.
Shilpa Medicare Ltd. EMA & SMA
915.00
↓
-0.82%
CURRENT PRICE
Bullish Moving Averages
Bearish Moving Averages
5 Day
910.0
10 Day
899.2
12 Day
897.1
20 Day
891.1
26 Day
885.0
50 Day
851.7
100 Day
806.3
200 Day
759.1
5 Day
910.1
10 Day
891.5
20 Day
882.9
30 Day
903.2
50 Day
856.0
100 Day
755.5
150 Day
759.3
200 Day
781.9
Shilpa Medicare Ltd. DELIVERY AND VOLUME
Daily Avg. Delivery Volume %
| 17 Jul, 2025 | Week | Month |
|---|---|---|
| 100.0% | 100.0% | 100.0% |
Shilpa Medicare Ltd. ACTIVE CANDLESTICKS
Bearish Harami
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
Shilpa Medicare Ltd. RESISTANCE AND SUPPORT
919.48
PIVOT
First Resistance
937.5
Second Resistance
952.4
Third Resistance
970.4
First Support
904.6
Second Support
886.6
Third Support
871.7
Shilpa Medicare Ltd. BETA
1 Month
-1.0
1 Year
1.2
3 Months
0.5
3 Years
0.8
Shilpa Medicare Ltd. PRICE CHANGE ANALYSIS
↓
-2.1%
Over 1 Month
Low
High
820.9
937.1
↑
36.9%
Over 3 Months
Low
High
613.2
1000
↑
13.5%
Over 6 Months
Low
High
555
1000
↑
41.2%
Over 1 Year
Low
High
555
1000
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| THE VANGUARD GROUP INC AC VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND | Bulk | Purchase | 21 Mar 2025 | 683.03 | 547,853 | NSE |
| UBS PRINCIPAL CAPITAL ASIA LIMITED | Block | Sell | 23 Jan 2025 | 818.05 | 163,006 | NSE |
| UBS AG | Block | Purchase | 23 Jan 2025 | 818.05 | 163,006 | NSE |
| PLUTUS WEALTH MANAGEMENT LLP | Bulk | Purchase | 05 Jun 2024 | 492.34 | 750,000 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 21 Feb 2024 | 444.09 | 482,523 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Purchase | 21 Feb 2024 | 443.95 | 482,523 | NSE |
| TA FII INVESTORS LIMITED | Bulk | Sell | 20 Feb 2024 | 422.22 | 500,000 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 19 Feb 2024 | 404.48 | 578,067 | NSE |
| TA FII INVESTORS LIMITED | Bulk | Sell | 19 Feb 2024 | 407.05 | 1,345,000 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Purchase | 19 Feb 2024 | 404.63 | 578,067 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 30 Jun 2023 | 273.06 | 771,081 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Purchase | 30 Jun 2023 | 272.92 | 771,081 | NSE |
| JAYESH DHIRAJLAL PAREKH | Bulk | Purchase | 22 Jun 2023 | 251.90 | 490,000 | BSE |
| NALINI DHIRAJLAL PAREKH | Bulk | Sell | 22 Jun 2023 | 251.90 | 490,000 | BSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 20 Jun 2023 | 261.36 | 724,154 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Purchase | 20 Jun 2023 | 261.23 | 724,154 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 11 Apr 2023 | 260.38 | 791,181 | NSE |
| XTX MARKETS LLP | Bulk | Sell | 11 Apr 2023 | 262.18 | 690,900 | NSE |
| NK SECURITIES RESEARCH PRIVATE LIMITED | Bulk | Sell | 11 Apr 2023 | 262.14 | 487,414 | NSE |
| QE SECURITIES | Bulk | Sell | 11 Apr 2023 | 263.30 | 922,098 | NSE |
| NK SECURITIES RESEARCH PRIVATE LIMITED | Bulk | Purchase | 11 Apr 2023 | 262 | 487,414 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Purchase | 11 Apr 2023 | 260.25 | 791,181 | NSE |
| XTX MARKETS LLP | Bulk | Purchase | 11 Apr 2023 | 261.70 | 702,279 | NSE |
| QE SECURITIES | Bulk | Purchase | 11 Apr 2023 | 263.48 | 932,505 | NSE |
| INDIA OPPORTUNITIES GROWTH FUND LTD-PINEWOOD STRATEGY | Bulk | Sell | 28 Mar 2023 | 225.30 | 500,000 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 09 Mar 2023 | 277.63 | 758,789 | NSE |
| QE SECURITIES | Bulk | Sell | 09 Mar 2023 | 278.08 | 493,487 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Purchase | 09 Mar 2023 | 277.55 | 758,789 | NSE |
| QE SECURITIES | Bulk | Purchase | 09 Mar 2023 | 278.57 | 491,891 | NSE |
| XTX MARKETS LLP | Bulk | Sell | 21 Feb 2023 | 294.70 | 541,358 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 21 Feb 2023 | 295.06 | 819,255 | NSE |
| QE SECURITIES | Bulk | Sell | 21 Feb 2023 | 294.86 | 525,040 | NSE |
| QE SECURITIES | Bulk | Purchase | 21 Feb 2023 | 295.09 | 525,746 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Purchase | 21 Feb 2023 | 294.87 | 819,255 | NSE |
| XTX MARKETS LLP | Bulk | Purchase | 21 Feb 2023 | 294.06 | 551,175 | NSE |
| XTX MARKETS LLP | Bulk | Sell | 17 Feb 2023 | 284.21 | 430,654 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 17 Feb 2023 | 281.34 | 549,440 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Purchase | 17 Feb 2023 | 280.99 | 549,440 | NSE |
| XTX MARKETS LLP | Bulk | Purchase | 17 Feb 2023 | 283.75 | 440,556 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 23 Dec 2022 | 291.54 | 457,291 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Purchase | 23 Dec 2022 | 290.96 | 457,291 | NSE |
| PIVOTAL BUSINESS MANAGERS LLP | Block | Sell | 21 Oct 2022 | 330.70 | 835,000 | BSE |
| PIVOTAL BUSINESS MANAGERS LLP | Block | Sell | 21 Oct 2022 | 330.70 | 370,000 | BSE |
| PIVOTAL BUSINESS MANAGERS LLP | Block | Sell | 21 Oct 2022 | 330.70 | 306,667 | BSE |
| PIVOTAL BUSINESS MANAGERS LLP | Block | Sell | 21 Oct 2022 | 330.70 | 303,333 | BSE |
| NALINI DHIRAJLAL PAREKH | Block | Purchase | 21 Oct 2022 | 330.70 | 835,000 | BSE |
| BIMAL JASVANTLAL PAREKH | Block | Purchase | 21 Oct 2022 | 330.70 | 370,000 | BSE |
| ARUN JAYANTILAL SHAH | Block | Purchase | 21 Oct 2022 | 330.70 | 306,667 | BSE |
| MALIKA BIMAL PAREKH | Block | Purchase | 21 Oct 2022 | 330.70 | 303,333 | BSE |
| NALINI DHIRAJLAL PAREKH | Bulk | Purchase | 21 Oct 2022 | 330.70 | 835,000 | BSE |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Sep, 2022 | 1.10 | FINAL | Equity Share | |
| 20 Sep, 2021 | 1.10 | FINAL | Equity Share | |
| 16 Mar, 2020 | 1.10 | INTERIM | 17 Mar, 2020 | Equity Share |
| 12 Sep, 2019 | 1.00 | FINAL | Equity Share | |
| 01 Mar, 2018 | 0.70 | INTERIM | 05 Mar, 2018 | Equity Share |
| 21 Mar, 2017 | 0.60 | INTERIM | 22 Mar, 2017 | Equity Share |
| 28 Mar, 2016 | 0.60 | INTERIM | 29 Mar, 2016 | Equity Share |
| 16 Sep, 2015 | 1.10 | FINAL | Equity Share | |
| 11 Sep, 2014 | 1.00 | FINAL | Equity Share | |
| 16 Jul, 2013 | 1.30 | FINAL | Equity Share | |
| 17 Sep, 2012 | 0.90 | FINAL | Equity Share | |
| 15 Sep, 2011 | 0.80 | FINAL | Equity Share | |
| 16 Sep, 2010 | 0.70 | FINAL | Equity Share | |
| 24 Sep, 2009 | 0.50 | FINAL | Equity Share | |
| 11 Sep, 2008 | 0.40 | FINAL | Equity Share | |
| 24 May, 2007 | 2.00 | INTERIM | 26 May, 2007 | Equity Share |
| 23 Sep, 2005 | 1.50 | FINAL | Equity Share |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| 16 Jul, 2013 | 1:2 |
| Ex-Date | Old FV | New FV | Record Date |
|---|---|---|---|
| 06 Nov, 2015 | 2 | 1 | |
| 28 Sep, 2007 | 10 | 2 | 08 Oct, 2007 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| 26 May, 2025 | Audited Results & Final Dividend | |
| 10 Feb, 2025 | Quarterly Results | |
| 13 Nov, 2024 | Quarterly Results | |
| 08 Aug, 2024 | Quarterly Results | |
| 23 May, 2024 | Audited Results & Final Dividend | |
| 08 Feb, 2024 | Quarterly Results | |
| 10 Nov, 2023 | Quarterly Results | |
| 10 Aug, 2023 | Quarterly Results | |
| 23 Jun, 2023 | Rights issue of Equity Shares | |
| 25 May, 2023 | Audited Results |